Skip to main content
Clinical Trials/NCT01049321
NCT01049321CompletedPhase 4

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Isfahan University of Medical Sciences1 site in 1 country36 target enrollmentStarted: December 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
36
Locations
1
Primary Endpoint
Cardio-metabolic risks

Study Overview

Brief Summary

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
44 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Having type 2 diabetes

Exclusion Criteria

  • •Having other chronic disease, hepatic or kidney disorders, cancer, hormone therapy

Arms & Interventions

DASH diet

Experimental

DASH: Dietary approaches to stop hypertension eating plan

Intervention: DASH diet (Dietary Supplement)

Diabetic diet

Placebo Comparator

Diabetic diet: a usual diabetic diet

Intervention: a usual diabetic diet (Dietary Supplement)

Outcomes

Primary Outcomes

Cardio-metabolic risks

Time Frame: 6 months

Secondary Outcomes

  • Hepatic function(6 months)

Investigators

Study Sites (1)

Loading locations...

Similar Trials